Aquestive Therapeutics, Inc. - COM (AQST)

Historical Portfolio Holders from Q3 2018 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
42.4M
Holdings value Q2 2024
$110M
Value change Q2 2024
-$9.12M
Grand Portfolio weight change Q2 2024
0%
Number of holders
94
Number of buys Q2 2024
17
Number of sells Q2 2024
-7
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.2M $11M +$1.11M $4.98 23
2024 Q2 42.4M $110M -$9.12M $2.60 94
2024 Q1 41.5M $177M +$88.1M $4.26 96
2023 Q4 23.8M $48.1M +$1.93M $2.02 57
2023 Q3 13.1M $20M +$5.8M $1.53 45
2023 Q2 19.1M $31.5M +$6.9M $1.65 54
2023 Q1 14.9M $17M +$182K $1.14 35
2022 Q4 14.9M $13.5M -$924K $0.90 34
2022 Q3 15.9M $18.6M -$701K $1.17 41
2022 Q2 16.7M $10.7M -$1.11M $0.64 37
2022 Q1 15.5M $40.6M -$1.91M $2.61 49
2021 Q4 16.2M $62.9M +$1.54M $3.89 50
2021 Q3 14.8M $64.4M -$3.39M $4.36 44
2021 Q2 15.6M $62M -$6.4M $3.97 57
2021 Q1 16.6M $86.4M -$13.3M $5.20 62
2020 Q4 19.1M $102M -$3.89M $5.35 65
2020 Q3 19.9M $96.5M +$6.73M $4.85 59
2020 Q2 18.5M $90M +$16.4M $4.86 58
2020 Q1 16M $35M -$11.3M $2.19 42
2019 Q4 17.5M $101M +$20.8M $5.82 55
2019 Q3 13.6M $43.2M -$3.72M $3.18 34
2019 Q2 14.5M $61M -$1M $4.20 39
2019 Q1 14.4M $99.6M +$442K $6.91 49
2018 Q4 14.4M $90.5M -$232M $6.30 35
2018 Q3 16.1M $282M +$282M $17.51 44